About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristant #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Docs at BIO: Ernst & Young Hosts Super Session Addressing Financial Performance of Biotech Industry | Main | Docs at BIO: Steve Burrill's State of the Biotechnology Industry Report 2009 »

May 19, 2009

Comments

Donald,

Very nice report. What was his take on the impact of Bilski, etc on personalized medicine?

Saddlepack:

I believe Mr. Barrett's objective was to highlight the patent-related obstacles facing companies involved in the field of personalized medicine. Since the well-attended session included only a handful of patent attorneys, Mr. Barrett's decision to provide an overview (and touch on a number of different topics) was probably a good one. As a result, he did not go into too much detail regarding the possible impact of Bilski and its progeny. Nevertheless, I think Mr. Barrett would likely agree that until the Federal Circuit provides more direction on this issue, or the biotech patent community figures out a good strategy for claiming inventions in this field, Bilski and its progeny will, at least for now, have a negative impact.

Thanks for the comment.

Don

The comments to this entry are closed.

May 2019

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31